Plain-English translation of NCT06736678 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing an oral immunonutrition therapy—a specially formulated nutritional supplement designed to support your immune system—to see if it can reduce the tough side effects that happen during chemotherapy and radiation treatment for pancreatic cancer. You would take this supplement for 6 weeks, starting one week before your radiation therapy begins. The goal is to help your body handle the treatment better and stay stronger throughout your care.
Chemotherapy and radiation can cause serious side effects that make treatment harder to complete and recovery slower. Research in other cancers has shown that specialized nutritional support can help reduce these side effects, but this approach hasn't been studied yet in pancreatic cancer patients receiving radiation, which is why doctors want to test it now.
You would start taking the oral nutritional supplement one week before your chemotherapy and radiation therapy begins, and continue taking it for 6 weeks total. The supplement comes in a form you drink or consume by mouth at home. You'll have follow-up visits with the research team over 4 months to track how you're doing, what side effects you experience, and how well the supplement is working. Your doctors will monitor your nutrition, overall health, and how you're tolerating your cancer treatment.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
China